Merilee Raines - 20 Sep 2021 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Director
Signature
/s/ Donald Notman, Attorney-in-Fact for Merilee Raines
Issuer symbol
OCUL
Transactions as of
20 Sep 2021
Net transactions value
$0
Form type
4
Filing time
22 Sep 2021, 08:19:56 UTC
Previous filing
02 Aug 2021
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUL Stock Option (Right to Buy) Award $0 +36,000 $0.000000 36,000 20 Sep 2021 Common Stock 36,000 $10.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over three years, vesting 1/3 on each yearly anniversary of the date of grant.